Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Cannabinoids, Neural Synchrony, and Information Processing

Early Phase 1

Completed

Conditions: Psychotic Disorders
Cannabis

Interventions: Drug: Placebo
Drug: THC

First Posted Date: 2008-07-03

Last Posted Date: 2022-03-09

Lead Sponsor: Yale University

Target Recruit Count: 42

Registration Number: NCT00708994

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers

Phase 1

Completed

Conditions: Endometrial Cancer

Interventions: Drug: Topotecan
Drug: RAD001

First Posted Date: 2008-06-24

Last Posted Date: 2014-01-14

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT00703807

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Effect of Music Therapy on Patients Undergoing Intravitreal Injections

Completed

Conditions: Patient Satisfaction
Patient Anxiety
Intravitreal Injections

Interventions: Other: No Music
Other: Music Therapy

First Posted Date: 2008-06-19

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT00702039

Locations: 🇺🇸
Yale Eye Center, New Haven, Connecticut, United States

Studies on Aldosterone and Vascular Function

Phase 1

Completed

Conditions: Inflammation

Interventions: Dietary Supplement: low or high sodium diet
Drug: aldosterone
Drug: placebo

First Posted Date: 2008-06-18

Last Posted Date: 2008-06-18

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT00700479

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Effects of Salvinorin A in Healthy Controls

Early Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Salvinorin A

First Posted Date: 2008-06-18

Last Posted Date: 2022-04-07

Lead Sponsor: Yale University

Target Recruit Count: 105

Registration Number: NCT00700596

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy

Phase 2

Completed

Conditions: Alcohol Drinking

Interventions: Drug: 21mg transdermal nicotine patch (Nicoderm CQ)
Drug: 1mg nicotine nasal spray
Drug: placebo nasal spray

First Posted Date: 2008-06-18

Last Posted Date: 2018-03-12

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT00699556

Locations: 🇺🇸
Connecticut Mental Health Center & Yale-New Haven Hospital, New Haven, Connecticut, United States

Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ketamine and Org 25935
Drug: Placebo and Ketamine

First Posted Date: 2008-06-18

Last Posted Date: 2022-03-03

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT00700076

Locations: 🇺🇸
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States

Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma

Phase 1

Completed

Conditions: Myeloma

Interventions: Drug: Lenalidomide
Biological: Monocyte derived DCs loaded with KRN7000

First Posted Date: 2008-06-17

Last Posted Date: 2016-06-21

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT00698776

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Subjects

Interventions: Drug: Ketamine and Nicotine
Drug: Placebo
Drug: Nicotine
Drug: Ketamine

First Posted Date: 2008-06-04

Last Posted Date: 2012-05-09

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT00690170

Locations: 🇺🇸
Veterans Administration Hospital, West Haven, Connecticut, United States

TEENCOPE: An Internet Coping Skills Training Program for Teens With Type 1 Diabetes

Phase 3

Completed

Conditions: Type 1 Diabetes

Interventions: Behavioral: TeenCope
Behavioral: Managing Diabetes

First Posted Date: 2008-05-26

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 320

Registration Number: NCT00684658

Locations: 🇺🇸
Yale University School of Nursing, New Haven, Connecticut, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
University of Miami, Miami, Florida, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy